These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 27568002)

  • 21. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
    Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
    J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
    Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
    BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
    Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
    Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities.
    Voon P; Ti L; Dong H; Milloy MJ; Wood E; Kerr T; Hayashi K
    BMC Public Health; 2016 Jun; 16():476. PubMed ID: 27266703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
    Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
    Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users.
    Doshi RK; Vogenthaler NS; Lewis S; Rodriguez A; Metsch L; del Rio C
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1007-14. PubMed ID: 22214200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy.
    Viswanathan S; Justice AC; Alexander GC; Brown TT; Gandhi NR; McNicholl IR; Rimland D; Rodriguez-Barradas MC; Jacobson LP
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):493-8. PubMed ID: 25886923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Analysis of two Methods of Measuring Antiretroviral Therapy Adherence in HIV-Infected Omani Patients.
    Gaifer Z; Boulassel MR
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219867316. PubMed ID: 31389287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).
    Viswanathan S; Detels R; Mehta SH; Macatangay BJ; Kirk GD; Jacobson LP
    AIDS Behav; 2015 Apr; 19(4):601-11. PubMed ID: 25342151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers to Viral Suppression Among Female Sex Workers: Role of Structural and Intimate Partner Dynamics.
    Duff P; Goldenberg S; Deering K; Montaner J; Nguyen P; Dobrer S; Shannon K
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):83-90. PubMed ID: 27513573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users.
    Kerr T; Marshall BD; Milloy MJ; Zhang R; Guillemi S; Montaner JS; Wood E
    Drug Alcohol Depend; 2012 Jul; 124(1-2):108-12. PubMed ID: 22245312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.
    Calvo-Cidoncha E; González-Bueno J; Almeida-González CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2015 Feb; 21(2):153-7. PubMed ID: 25615004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.
    Lee WK; Milloy MJS; Nosova E; Walsh J; Kerr T
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):103-109. PubMed ID: 30300214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.